The β1 adrenergic effects of antibodies against the C-terminal end of the ribosomal P2β protein of Trypanosoma cruzi associate with a specific pattern of epitope recognition

Clinical and Experimental Immunology

Volumn 142, Issue 1, 2005, Pages 140-147

  Bergami, P Lopez ^a   Gomez K A ^a   Levy, G V ^a   Grippo, V ^a   Baldi, A ^b   Levin, Mariano J ^a,c  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

^c INSTITUTO DE INVESTIGACIONES EN INGENIERÍA GENÉTICA Y BIOLOGÍA MOLECULAR   (Argentina)

Author keywords

1 adrenergic receptor; Pathogenic antibodies; Ribosomal P proteins; Trypanosoma cruzi

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; EPITOPE; GLUTAMYLGLUTAMYLGLUTAMYLASPARTYLASPARTYLASPARTYLMETHIONYLGLYCYLPHENYLALANYLGLYCYLLEUCYLPHENYLALANYLASPARTIC ACID; PEPTIDE; PROTEIN ANTIBODY; PROTEIN TCP2BETA; PROTOZOAL PROTEIN; RIBOSOME PROTEIN; UNCLASSIFIED DRUG; AUTOANTIBODY; IMMUNOGLOBULIN G; PROTOZOON ANTIBODY; RECOMBINANT PROTEIN;

ADRENERGIC ACTIVITY; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; EPITOPE MAPPING; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MOTIF; SUPRAVENTRICULAR TACHYCARDIA; TRYPANOSOMA CRUZI; ANIMAL; AUTOIMMUNITY; BAGG ALBINO MOUSE; CHAGAS DISEASE; IMMUNOLOGY; METHODOLOGY; PATHOPHYSIOLOGY;

ANIMALS; ANTIBODIES, PROTOZOAN; AUTOANTIBODIES; AUTOIMMUNITY; CHAGAS DISEASE; ELECTROCARDIOGRAPHY; EPITOPE MAPPING; EPITOPES; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; PROTOZOAN PROTEINS; RECEPTORS, ADRENERGIC, BETA-1; RECOMBINANT PROTEINS; RIBOSOMAL PROTEINS; TRYPANOSOMA CRUZI;

EID: 25444464356     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2005.02885.x     Document Type: Article

References (24)

1. Elizari MV, Chiale PA. Pharmacologic treatment of arrhythmias related to chronic Chagas' heart disease. In: Tentori MC, Segura E, Hayes DL, eds. Arrhytmia management in Chagas' disease. Armonk, New York: Futura Publishing Co., 2000:95-116.
2. Chiale PA, Ferrari I, Mahler E et al. Differential profile and biochemical effects of antiautonomic membrane receptor antibodies in ventricular arrhythmias and sinus node dysfunction. Circulation 2001; 103:1765-71.
3. Borda E, Sterin-Borda L. Antiadrenergic and muscarinic receptor antibodies in Chagas' cardiomyopathy. Int J Cardiol 1996; 54:149-56.
4. Kierszenbaum F. Chagas' disease and the autoimmunity hypothesis. Clin Microbiol Rev 1999; 12:210-23.
5. Kaplan D, Ferrari I, Lopez Bergami P et al. Antibodies to ribosomal P proteins of Trypanosoma cruzi in Chagas' disease possess functional autoreactivity with heart tissue and differ from anti-P autoantibodies in lupus. Proc Natl Acad Sci USA 1997; 94:10301-6.
6. Elies R, Ferrari I, Wallukat G et al. Structural and functional analysis of the B cell epitopes recognized by anti-receptor autoantibodies in patients with Chagas' disease. J Immunol 1996; 157:4203-11.
7. Masuda M, Levin MJ, Farias de Oliveira S et al. Functionally active cardiac antibodies in chronic Chagas' disease are specifically blocked by Trypanosoma cruzi antigens. FASEB J 1998; 12:1551-8.
8. Lopez Bergami P, Scaglione J, Levin MJ. Antibodies against the carboxyl-terminal end of the Trypanosoma cruzi ribosomal P proteins are pathogenic. FASEB J 2001; 15:2602-12.
9. Lopez Bergami P, Cabeza Meckert P, Kaplan D et al. Immunization with recombinant Trypanosoma cruzi ribosomal P2β protein induces changes in the electrocardiogram of immunized mice. FEMS Immunol Med Microbiol 1997; 18:75-85.
10. Muller S, Couppez M, Briand JP, Gordon J, Sautiere P, van Regenmortel MH. Antigenic structure of histone H2B. Biochim Biophys Acta 1985; 827:235-46.
11. Levin MJ, Vazquez M, Kaplan D, Schijman AG. The Trypanosoma cruzi ribosomal P protein family: classification and antigenicity. Parasitol Today 1993; 9:381-4.
12. Elkon K, Bonfa E, Llovet R, Danho W, Weissbach H, Brot N. Properties of the ribosomal P2 protein autoantigen are similar to those of foreign protein antigens. Proc Natl Acad Sci USA 1988; 85:5186-9.
13. Magnusson Y, Hoyer S, Lengagne R et al. Antigenic analysis of the second extra-cellular loop of the human beta-adrenergic receptors. Clin Exp Immunol 1989; 78:42-8.
14. Mesri E, Levitus G, Hontebeyrie-Joskowicz M et al. Major Trypanosoma cruzi determinant in Chagas' heart disease shares homology with the systemic lupus erythematosus ribosomal P protein epitope. J Clin Microbiol 1990; 28:1219-24.
15. Hines JJ, Weissbach H, Brot N, Elkon K. Anti-P autoantibody production requires P1/P2 as immunogen but is not driven by exogenous self-antigen in MLR mice. J Immunol 1991; 146:3386-95.
16. Sepulveda P, Liegeard P, Wallukat G, Levin MJ, Hontebeyrie M. Modulation of cardiocyte functional activity by antibodies against Trypanosoma cruzi ribosomal P2 protein C-terminus. Infect Immunol 2000; 68:5114-9.
17. Elkon K, Bonfa E, Skeky S et al. Ribosomal protein autoantibodies in systemic lupus erythematosus. Bioessays 1987; 7:258-61.
18. Mahler E, Hoebeke J, Levin MJ. Structural and functional complexity of the humoral response against the Trypanosoma cruzi ribosomal P2 β protein in patients with chronic Chagas' heart disease. Clin Exp Immunol 2004; 136:527-34.
19. Mahler E. Rol de las proteínas P de Trypanosoma cruzi en la generación de anticuerpos con autorreactividad funcional en la cardiomiopatía crónica chagásica. PhD thesis, University of Buenos Aires, 2002.
20. Mahler M, Kessenbrock K, Raats J, Williams R, Fritzler MJ, Bluthner M. Characterization of the human autoimmune response to the major C-terminal epitope of the ribosomal P proteins. Mol Med 2003 March; 81:194-204.
21. Zampieri S, Mahler M, Bluthner M et al. Recombinant anti-P protein autoantibodies isolated from a human autoimmune library: reactivity, specificity and epitope recognition. Cell Mol Life Sci 2003; 60:588-98.
22. Sun B, Rizzo LV, Sun S-H et al. Genetic susceptibility to experimental autoimmune uveitis involves more than a predisposition to generate a T helper-1-like or a T helper-2-like response. J Immunol 1997; 159:1004-11.
23. Scott P. IFN-γ modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J Immunol 1991; 147:3149-55.
24. Keane-Myers A, Nickell SP. Role of IL-4 and IFN-γ in modulation of immunity to Borrelia burgdorferi in mice. J Immunol 1995; 155:2020-8.